Understanding how dopamine helps us learn from rewards and punishments
Striatal Dopamine Signals Underlying Valence-Dependent Learning
This study looks at how dopamine helps us learn from both good and bad experiences, and it's especially important for people with Parkinson's disease who may struggle with learning due to issues with dopamine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10881346 on NIH RePORTER |
What this research studies
This research investigates the role of dopamine in learning from both rewards and punishments, focusing on how these signals are processed in different areas of the striatum. By using advanced tools to record dopamine activity over extended periods, the study aims to uncover how dopamine influences valence-dependent learning, which is crucial for cognitive and motor functions. The research is particularly relevant for understanding deficits in learning associated with conditions like Parkinson's disease. Patients may benefit from insights that could lead to improved treatments for learning impairments related to dopamine dysfunction.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with Parkinson's disease or other conditions that affect dopamine signaling and learning.
Not a fit: Patients without dopamine-related disorders or those not experiencing learning impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for patients with dopamine-related disorders, enhancing their learning and cognitive abilities.
How similar studies have performed: Previous research has shown promising results in understanding dopamine's role in reward learning, but this specific focus on valence-dependent learning is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Schwerdt, Helen N — University of Pittsburgh at Pittsburgh
- Study coordinator: Schwerdt, Helen N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.